Use of sodium thiosulfate leads to adverse events for patients on peritoneal dialysis

AUSTIN, Texas — Use of sodium thiosulfate to treat calciphylaxis in patients on peritoneal dialysis can be successful, but adverse effects may occur, according to data presented at the National Kidney Foundation Spring Clinical Meetings.
Sodium thiosulfate for the treatment of calciphylaxis is well studied in patients on hemodialysis but not in patients on peritoneal dialysis, Christy

Related Keywords

Minnesota ,United States ,Mayo Clinic In Rochester ,Florida ,Texas ,Christyl Gossett ,Gina Brockenbrough ,Bymarke Neumann , ,National Kidney Foundation Spring Clinical Meetings ,Editorial Advisory Board Member ,Nephrology News ,National Kidney Foundation Spring Clinical ,Mayo Clinic ,